Improved Control of Secondary Hyperparathyroidism in Hemodialysis Patients Switching from Oral Cinacalcet to Intravenous Etelcalcetide, Especially in Nonadherent Patients
Sign Up to like & getrecommendations! Published in 2019 at "Blood Purification"
DOI: 10.1159/000496562
Abstract: Background: Etelcalcetide is a novel second-generation calcimimetic that, because of its intravenous administration, could improve treatment adherence in secondary hyperparathyroidism (SHPT). The aim of this study was to evaluate the effectiveness of etelcalcetide compared with… read more here.
Keywords: hemodialysis; ipth; especially nonadherent; cinacalcet ... See more keywords